{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:16:14Z","timestamp":1780755374990,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-01932-0","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:09:41Z","timestamp":1758805781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Global burden of chronic liver disease due to NAFLD from 2012 to 2021: A trend, decomposition, and health inequality analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Yanrui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongbiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhai","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"1932_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337.","journal-title":"J Hepatol"},{"key":"1932_CR2","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","volume":"72","author":"JM Paik","year":"2020","unstructured":"Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 2020;72:1605\u201316.","journal-title":"Hepatology"},{"key":"1932_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335\u201347.","journal-title":"Hepatology"},{"key":"1932_CR4","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537\u201364.","journal-title":"Cell"},{"key":"1932_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","volume":"19","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Stepanova M, Ong J, Trimble G, AlQahtani S, Younossi I, et al. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States. Clin Gastroenterol Hepatol. 2021;19:580\u20139.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1932_CR6","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386.","journal-title":"Hepatology"},{"key":"1932_CR7","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","volume":"80","author":"SJ Song","year":"2024","unstructured":"Song SJ, Lai JC, Wong GL, Wong VW, Yip TC. Can we use old NAFLD data under the new MASLD definition? J Hepatol. 2024;80:e54\u20136.","journal-title":"J Hepatol"},{"key":"1932_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","volume":"76","author":"PK Luukkonen","year":"2022","unstructured":"Luukkonen PK, Qadri S, Ahlholm N, Porthan K, M\u00e4nnist\u00f6 V, Sammalkorpi H, et al. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2022;76:526\u201335.","journal-title":"J Hepatol"},{"key":"1932_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1932_CR10","doi-asserted-by":"publisher","first-page":"e70091","DOI":"10.1111\/liv.70091","volume":"45","author":"A Ramandi","year":"2025","unstructured":"Ramandi A, Diehl AM, Sanyal AJ, de Jong YP. Experimental models to investigate PNPLA3 in liver steatosis. Liver Int. 2025;45:e70091.","journal-title":"Liver Int"},{"key":"1932_CR11","doi-asserted-by":"publisher","first-page":"e16123","DOI":"10.1111\/liv.16123","volume":"45","author":"J Kozlitina","year":"2025","unstructured":"Kozlitina J, Sookoian S. Global epidemiological impact of PNPLA3 I148M on liver disease. Liver Int. 2025;45:e16123.","journal-title":"Liver Int"},{"key":"1932_CR12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2133\u201361.","journal-title":"Lancet"},{"key":"1932_CR13","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2100\u201332.","journal-title":"Lancet"},{"key":"1932_CR14","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2162\u2013203.","journal-title":"Lancet"},{"key":"1932_CR15","volume-title":"Global burden of disease study 2021 (GBD 2021) Socio-Demographic index (SDI) 1950\u20132021","author":"Global Burden of Disease Collaborative Network","year":"2024","unstructured":"Global Burden of Disease Collaborative Network. Global burden of disease study 2021 (GBD 2021) Socio-Demographic index (SDI) 1950\u20132021. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2024."},{"key":"1932_CR16","volume-title":"Global burden of disease study 2021 (GBD 2021) results","author":"Global Burden of Disease Collaborative Network","year":"2022","unstructured":"Global Burden of Disease Collaborative Network. Global burden of disease study 2021 (GBD 2021) results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2022."},{"key":"1932_CR17","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28:3670\u201382.","journal-title":"Stat Med"},{"key":"1932_CR18","first-page":"171","volume":"50","author":"P Das Gupta","year":"1994","unstructured":"Das Gupta P. Standardization and decomposition of rates from cross-classified data. Genus. 1994;50:171\u201396.","journal-title":"Genus"},{"key":"1932_CR19","volume-title":"Handbook on health inequality monitoring, with a special focus on low- and middle-income countries","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Handbook on health inequality monitoring, with a special focus on low- and middle-income countries. Geneva: World Health Organization; 2013."},{"key":"1932_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"1932_CR21","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2017","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627\u201342.","journal-title":"Lancet"},{"key":"1932_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402:203\u201334.","journal-title":"Lancet"},{"key":"1932_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1186\/s12889-016-3489-8","volume":"16","author":"JP Tripathy","year":"2016","unstructured":"Tripathy JP, Thakur JS, Jeet G, Chawla S, Jain S, Prasad R. Urban rural differences in diet, physical activity and obesity in india: are we witnessing the great Indian equalisation? Results from a cross-sectional STEPS survey. BMC Public Health. 2016;16:816.","journal-title":"BMC Public Health"},{"key":"1932_CR24","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(19)30179-2","volume":"7","author":"F Azizi","year":"2019","unstructured":"Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, et al. Metabolic health in the middle East and North Africa. Lancet Diabetes Endocrinol. 2019;7:866\u201379.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1932_CR25","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70:1457\u201369.","journal-title":"Hepatology"},{"key":"1932_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fendo.2014.00195","volume":"5","author":"AM Lundsgaard","year":"2014","unstructured":"Lundsgaard AM, Kiens B. Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity. Front Endocrinol (Lausanne). 2014;5:195.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1932_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/hep.510290307","volume":"29","author":"M Yasuda","year":"1999","unstructured":"Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology. 1999;29:719\u201327.","journal-title":"Hepatology"},{"key":"1932_CR28","doi-asserted-by":"publisher","first-page":"e13236","DOI":"10.1111\/eci.13236","volume":"50","author":"S Ministrini","year":"2020","unstructured":"Ministrini S, Montecucco F, Sahebkar A, Carbone F. Macrophages in the pathophysiology of NAFLD: the role of sex differences. Eur J Clin Invest. 2020;50:e13236.","journal-title":"Eur J Clin Invest"},{"key":"1932_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.maturitas.2018.07.008","volume":"116","author":"JA Santos-Marcos","year":"2018","unstructured":"Santos-Marcos JA, Rangel-Zu\u00f1iga OA, Jimenez-Lucena R, Quintana-Navarro GM, Garcia-Carpintero S, Malagon MM, et al. Influence of gender and menopausal status on gut microbiota. Maturitas. 2018;116:43\u201353.","journal-title":"Maturitas"},{"key":"1932_CR30","doi-asserted-by":"crossref","unstructured":"Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology. 2018;155:443\u201357.e17.","DOI":"10.1053\/j.gastro.2018.04.034"},{"key":"1932_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/2470289718787091","volume":"2","author":"S H\u00f6rist-Kollmann","year":"2018","unstructured":"H\u00f6rist-Kollmann S, Strametz-Juranek J. Female dietary patterns and the pathogenesis of NAFLD. Gend Genome. 2018;2:49\u201355.","journal-title":"Gend Genome"},{"key":"1932_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.arr.2015.08.003","volume":"24","author":"EF Fang","year":"2015","unstructured":"Fang EF, Scheibye-Knudsen M, Jahn HJ, Li J, Ling L, Guo H, et al. A research agenda for aging in China in the 21st century. Ageing Res Rev. 2015;24:197\u2013205.","journal-title":"Ageing Res Rev"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01932-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:09:43Z","timestamp":1758805783000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01932-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1932"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01932-0","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and consent were not required as this study was based on publicly available data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}